Drug Shortage Report for SANDOZ-CARBAMAZEPINE CR
| Report ID | 99058 |
| Drug Identification Number | 02261847 |
| Brand name | SANDOZ-CARBAMAZEPINE CR |
| Common or Proper name | CARBAMAZEPINE CR |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | CARBAMAZEPINE |
| Strength(s) | 400MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100 |
| ATC code | N03AF |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2019-11-04 |
| Estimated end date | 2019-11-29 |
| Actual end date | 2019-12-11 |
| Shortage status | Resolved |
| Updated date | 2020-01-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-01-22 | French | Compare |
| v3 | 2020-01-22 | English | Compare |
| v2 | 2019-11-18 | French | Compare |
| v1 | 2019-11-18 | English | Compare |
Showing 1 to 4 of 4